AstraZeneca to Create $1B Fund, R&D Centers in China
AstraZeneca’s China headquarters at Shanghai Zhangjiang Hi-Tech Park
AstraZeneca said today it will create new R&D centers focused on drug development and artificial intelligence (AI) in Shanghai, as well as partner with state-run China International...
New stem cell transplant lowers complications for patients with acute blood cancers
The discovery of the UM171 molecule, by Dr. Guy Sauvageau and Anne Marinier, made headlines in 2014 following an article in Science. Hailed by some as a revolution, even a miracle, in the field...
Study shows invasive blue catfish can tolerate high salinities
Indicates potential for further expansion in Chesapeake and into Delaware Bay
Credit: © VIMS Trawl Survey.
A new study by researchers at the Virginia Institute of Marine Science...
Risk factors of malignant arrhythmias found in patients treated with therapeutic hyperthermia after cardiac...
Researchers showed that 20-50% of patients developed an irregular heartbeat that required defibrillation during the active cooling phase of therapeutic hypothermia following an out-of-hospital cardiac arrest. Only patients with cardiogenic shock developed malignant arrhythmias...
HIMC at Mount Sinai to evaluate therapeutic effects of novel cancer immunotherapy
The Human Immune Monitoring Center (HIMC) at the Icahn School of Medicine at Mount Sinai will apply cutting-edge high-throughput technologies to evaluate the therapeutic effects of Libtayo® (cemiplimab-rwlc), a PD-1 antibody blockade developed by...
Allogene, Notch Partner to Develop iPSC-Derived Blood Cancer Therapies
Notch co-founder Juan Carlos Zúñiga-Pflücker, PhD.
Allogene Therapeutics will partner with Notch Therapeutics to research and develop induced pluripotent stem cell (iPSC) AlloCAR therapies for initial blood cancer indications that include non-Hodgkin lymphoma, leukemia, and...
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? – Nasdaq
Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the Invesco Dynamic Biotechnology & Genome ETF (PBE), a passively managed exchange traded fund launched on 06/23/2005.
Passively...
Innovative technique aims to predict and reduce fractures in diabetics
People with diabetes face a significantly higher risk of osteoporotic fractures than those without the disease, but the reason for this is not well understood and can't be adequately predicted. Researchers from Rensselaer Polytechnic...
2019 ESMO Award for Immuno-Oncology goes to Thomas Gajewski
ESMO Immuno-Oncology Congress, Dec. 11-14, 2019, Geneva, Switzerland
Credit: © European Society for Medical Oncology
Lugano, Switzerland, 5 November 2019 – The European Society for Medical Oncology (ESMO)...
Global Dihydrotanshinone Market 2019 – Shaanxi Undersun Biomedtech, Shaanxi Fuheng (FH) Biotechnology, Xi’an Huisun...
Global Dihydrotanshinone Market 2019 report contains wide-extending measurable details of Global Dihydrotanshinone Market, which enables the customer to separate the future maneuver and anticipate right execution.
A comprehensive theory of the Global Dihydrotanshinone market 2019...
